National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

methoxyamine
An orally bioavailable small molecule inhibitor with potential adjuvant activity. Methoxyamine covalently binds to apurinic/apyrimidinic (AP) DNA damage sites and inhibits base excision repair (BER), which may result in an increase in DNA strand breaks and apoptosis. This agent may potentiate the anti-tumor activity of alkylating agents. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Code name:TRC102



Previous:methotrexate, Methotrexate LPF, methotrexate-e therapeutic implant, methoxsalen, methoxy polyethylene glycol epoetin beta
Next:methyl-5-aminolevulinate hydrochloride cream, methylene blue, methylene dimethane sulfonate, methylmercaptopurine riboside, methylnaltrexone

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov